Finance

Lists
Why is N790 up 6,67%?
Dive Deeper
N790:FRA
LIR Life Sciences Corp
€0,13
+6,67%
(+0,0080) 1D
9 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for N790...
Open
€0,13
High
€0,13
Low
€0,13
Mkt. cap
6,32Ā m
Avg. vol.
1,42Ā k
Volume
0,00
52-wk high
€1,58
52-wk low
€0,08
Open
€0,13
High
€0,13
Low
€0,13
Mkt. cap
6,32Ā m
Avg. vol.
1,42Ā k
Volume
0,00
52-wk high
€1,58
52-wk low
€0,08
News stories
From web sources and news partners
About LIR Life Sciences Corp
CEO-
Employees-
Founded2018
HeadquartersVancouver, Brits-Columbiƫ, Kanada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Okt. 2025
Jan. 2026
Apr. 2026
Jul. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
6,67Ā k
5,00Ā k
Cost of revenue
-
-
6,67Ā k
5,00Ā k
Research and development expenses
-
10,00Ā k
52,10Ā k
255,17Ā k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
61,85Ā k
1,13Ā m
317,32Ā k
323,37Ā k
Operating expense
67,88Ā k
1,87Ā m
1,23Ā m
981,44Ā k
Total operating expenses
67,88Ā k
1,87Ā m
1,24Ā m
986,44Ā k
Operating income
-67,88Ā k
-1,87Ā m
-1,24Ā m
-986,44Ā k
Other non operating income
-6,52Ā k
-343,44Ā k
-57,71Ā k
-3,70Ā k
EBT including unusual items
-64,24Ā k
-2,16Ā m
-1,40Ā m
-989,04Ā k
EBT excluding unusual items
-196,00Ā k
-2,21Ā m
-1,30Ā m
-989,04Ā k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-64,24Ā k
-2,16Ā m
-1,40Ā m
-989,04Ā k
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
142,00
-
-
20,00
Interest expense
-
-
-
-
Net interest expenses
10,69Ā k
-
-
20,00
Depreciation and amortization charges
-
-
1,28Ā k
-
EBITDA
-64,40Ā k
-1,87Ā m
-1,24Ā m
-985,20Ā k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme